Literature DB >> 12163230

DHEA treatment: myth or reality?

Bruno Allolio1, Wiebke Arlt.   

Abstract

Dehydroepiandrosterone (DHEA) and its sulfate ester are major secretory products of the human adrenal. Serum DHEA concentrations decline with advancing age and DHEA supplementation in elderly people has been advertized as anti-aging medication. However, such claims are based on experiments in rodents with a fundamentally different DHEA physiology. In humans, DHEA is a crucial precursor of sex steroid biosynthesis and exerts indirect endocrine and intracrine actions following conversion to androgens and estrogens. In addition, it acts as a neurosteroid via effects on neurotransmitter receptors in the brain. DHEA has considerable effects on mood, well-being and sexuality in patients with adrenal insufficiency, and also in those with mood disorders. However, subjects with a physiological, age-related decline in DHEA secretion show little benefit from DHEA administration. Future research should focus on DHEA treatment for adrenal insufficiency, and DHEA administration in both patients receiving chronic glucocorticoid treatment and women with androgen deficiency.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12163230     DOI: 10.1016/s1043-2760(02)00617-3

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  29 in total

1.  Increased longevity due to sexual activity in mole-rats is associated with transcriptional changes in the HPA stress axis.

Authors:  Steve Hoffmann; Karol Szafranski; Philip Dammann; Arne Sahm; Matthias Platzer; Philipp Koch; Yoshiyuki Henning; Martin Bens; Marco Groth; Hynek Burda; Sabine Begall; Saskia Ting; Moritz Goetz; Paul Van Daele; Magdalena Staniszewska; Jasmin Mona Klose; Pedro Fragoso Costa
Journal:  Elife       Date:  2021-03-16       Impact factor: 8.140

2.  Dehydroepiandrosterone sulfate and bone resorption rates as reflected by serum levels of C-terminal telopeptide of type I collagen: a study in healthy men.

Authors:  V Carnevale; A Scillitani; E Vecci; E D'Erasmo; E Romagnoli; F Paglia; J Pepe; V Baldini; C Santori; S De Geronimo; S Minisola
Journal:  J Endocrinol Invest       Date:  2005-02       Impact factor: 4.256

Review 3.  Hormonal regulation of longevity in mammals.

Authors:  Holly M Brown-Borg
Journal:  Ageing Res Rev       Date:  2007-02-20       Impact factor: 10.895

Review 4.  Biomarkers related to aging in human populations.

Authors:  Eileen Crimmins; Sarinnapha Vasunilashorn; Jung Ki Kim; Dawn Alley
Journal:  Adv Clin Chem       Date:  2008       Impact factor: 5.394

Review 5.  Dehydroepiandrosterone (DHEA): hypes and hopes.

Authors:  Krzysztof Rutkowski; Paweł Sowa; Joanna Rutkowska-Talipska; Anna Kuryliszyn-Moskal; Ryszard Rutkowski
Journal:  Drugs       Date:  2014-07       Impact factor: 9.546

6.  Starr Responds.

Authors:  Ranjani R Starr
Journal:  Am J Public Health       Date:  2015-05-14       Impact factor: 9.308

7.  Songbirds: A novel perspective on estrogens and the aging brain.

Authors:  Barney A Schlinger; Colin J Saldanha
Journal:  Age (Dordr)       Date:  2006-02-17

Review 8.  [Hypogonadism in the elderly man. Reliable diagnosis and therapy].

Authors:  M Zitzmann; E Nieschlag
Journal:  Internist (Berl)       Date:  2003-10       Impact factor: 0.743

Review 9.  Estrogenic compounds, estrogen receptors and vascular cell signaling in the aging blood vessels.

Authors:  Dia A Smiley; Raouf A Khalil
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

10.  HE3286, an oral synthetic steroid, treats lung inflammation in mice without immune suppression.

Authors:  Douglas Conrad; Angela Wang; Raymond Pieters; Ferdinando Nicoletti; Katia Mangano; Anna M van Heeckeren; Steven K White; James M Frincke; Christopher L Reading; Dwight Stickney; Dominick L Auci
Journal:  J Inflamm (Lond)       Date:  2010-10-30       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.